CONMED Corporation (CNMD)
NYSE: CNMD
· Real-Time Price · USD
57.60
0.53 (0.93%)
At close: May 29, 2025, 3:59 PM
57.69
0.15%
After-hours: May 29, 2025, 04:07 PM EDT
CONMED Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|
| General Surgery Revenue | 763.03M | 711.59M | 583.94M | 572.21M | 367.45M | 341.42M | 274.19M | 279.36M | 286.75M |
| General Surgery Revenue Growth | +7.23% | +21.86% | +2.05% | +55.73% | +7.62% | +24.52% | -1.85% | -2.58% | n/a |
| Orthopedic Surgery Revenue | 543.99M | 533.16M | 461.53M | 438.42M | 428.94M | 370.47M | 388.95M | 402.75M | 410.17M |
| Orthopedic Surgery Revenue Growth | +2.03% | +15.52% | +5.27% | +2.21% | +15.78% | -4.75% | -3.43% | -1.81% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas (Excluding The United States) Revenue | 121.04M | 120.93M | 212.21M | 194.38M | 50.36M | 64.27M | 66.52M | 91.17M | 87.53M | 361.45M | 360.96M | 375.47M | 382.26M | 364.59M |
| Americas (Excluding The United States) Revenue Growth | +0.09% | -43.01% | +9.17% | +286.01% | -21.65% | -3.38% | -27.04% | +4.16% | -75.78% | +0.14% | -3.87% | -1.77% | +4.85% | n/a |
| Asia Pacific Revenue | 194.68M | 197.4M | 324.95M | 342.44M | 93.64M | 101.33M | 94.75M | 138.33M | 128.9M | n/a | n/a | n/a | n/a | n/a |
| Asia Pacific Revenue Growth | -1.38% | -39.25% | -5.11% | +265.71% | -7.60% | +6.95% | -31.51% | +7.32% | n/a | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue | 243.06M | 226.25M | 395.87M | 379.39M | 91M | 118.3M | 113M | 155.85M | 147.99M | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue Growth | +7.43% | -42.85% | +4.34% | +316.92% | -23.08% | +4.69% | -27.50% | +5.31% | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 748.22M | 700.16M | 1.16B | 1.11B | 139.72M | 179.42M | 172.46M | 411.04M | 399.11M | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +6.86% | -39.53% | +4.78% | +690.94% | -22.13% | +4.03% | -58.04% | +2.99% | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 148.85M | 132.67M | 99.73M | 121.84M | 106.1M | 127.33M | 125.3M | 129.7M | 130.08M | 120.74M | 114.6M | 115.83M | 102.88M | 107.28M | 104.74M | 104.4M | 98.34M | 99.1M | 94.38M | 84.47M | 95.87M | 102M | 98.19M | 100.73M | 99.23M | 96.46M | 84.98M | 89.6M | 84.57M | 92.41M | 80.81M | 83.83M | 94.76M | 86.72M | 79.01M | 86.73M | 85.94M | 82.67M | 72.06M | 73.58M | 74.79M |
| Selling, General, and Administrative Revenue Growth | +12.19% | +33.03% | -18.15% | +14.84% | -16.68% | +1.62% | -3.40% | -0.29% | +7.74% | +5.36% | -1.06% | +12.59% | -4.11% | +2.43% | +0.32% | +6.16% | -0.76% | +5.00% | +11.73% | -11.88% | -6.01% | +3.89% | -2.52% | +1.51% | +2.87% | +13.51% | -5.16% | +5.95% | -8.48% | +14.35% | -3.60% | -11.54% | +9.27% | +9.76% | -8.90% | +0.91% | +3.96% | +14.73% | -2.07% | -1.61% | n/a |
| Research and Development Revenue | 12.95M | 13.18M | 13.56M | 14.1M | 13.59M | 14.03M | 12.46M | 13.57M | 12.54M | 12.22M | 12.77M | 11.49M | 10.67M | 11.36M | 10.86M | 11.32M | 10.03M | 11.72M | 9.94M | 8.7M | 10.12M | 12.09M | 10.98M | 11.81M | 10.57M | 10.37M | 14.12M | 9.98M | 7.71M | 8.38M | 8.27M | 8.04M | 7.62M | 7.63M | 8.35M | 8.01M | 8.26M | 6.74M | 6.65M | 7.5M | 6.54M |
| Research and Development Revenue Growth | -1.74% | -2.82% | -3.83% | +3.71% | -3.09% | +12.55% | -8.16% | +8.24% | +2.61% | -4.28% | +11.09% | +7.69% | -6.06% | +4.62% | -4.06% | +12.88% | -14.42% | +17.91% | +14.21% | -14.03% | -16.32% | +10.10% | -6.95% | +11.64% | +1.97% | -26.56% | +41.43% | +29.49% | -7.96% | +1.31% | +2.85% | +5.55% | -0.21% | -8.61% | +4.30% | -3.02% | +22.50% | +1.34% | -11.32% | +14.66% | n/a |